Sight Sciences, Inc.
SGHT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $180 | $214 | $123 | $185 |
| - Cash | $92 | $102 | $109 | $120 |
| + Debt | $0 | $41 | $40 | $40 |
| Enterprise Value | $88 | $153 | $55 | $105 |
| Revenue | $20 | $20 | $18 | $19 |
| % Growth | 1.7% | 11.7% | -8.2% | – |
| Gross Profit | $17 | $17 | $15 | $17 |
| % Margin | 86.4% | 84.8% | 86.2% | 86.8% |
| EBITDA | -$7 | -$10 | -$13 | -$10 |
| % Margin | -34.3% | -53.6% | -72.5% | -54.9% |
| Net Income | -$8 | -$12 | -$14 | -$12 |
| % Margin | -41% | -61% | -80.8% | -62.1% |
| EPS Diluted | -0.16 | -0.23 | -0.28 | -0.23 |
| % Growth | 30.4% | 17.9% | -21.7% | – |
| Operating Cash Flow | -$9 | -$8 | -$12 | -$3 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$9 | -$8 | -$12 | -$4 |